Join the club for FREE to access the whole archive and other member benefits.

Survival doubled for gastrointestinal cancer patients taking Aspirin

28-Sep-2015

Key points from article :

Study of 14,000 people with cancer in gastrointestinal tract.

Regular users of aspirin were twice as likely to still be alive after four years.

Impact was seen after adjusting for factors such as gender, age, stage of cancer.

Mentioned in this article:

Click on resource name for more details.

Martine Frouws

PhD Candidate at Leiden University Medical Centre.

Peter Naredi

Head of the Institute of Clinical Sciences and Professor of Surgery, Sahlgrenska Academy, University of Gothenburg.

Topics mentioned on this page:
Cancer